Stanford Medcast Episode 7: COVID-19 Mini-series - Vaccines and Immunity

1. Evaluate the data on the safety of emerging vaccines, which are scheduled to be available by January 2021.

The Stanford University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.


Credit Designation
The Stanford University School of Medicine designates this Enduring Material for a maximum of 0.50 AMA PRA Category 1 Credits^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The California Board of Registered Nursing recognizes that Continuing Medical Education (CME) is acceptable for meeting RN continuing education requirements as long as the course is certified for AMA PRA Category 1 Credits^TM (rn.ca.gov).  Nurses will receive a Certificate of Participation following this activity that may be used for license renewal. The provider number is: 0000751.

References

1. Walsh, E.E., Frenck, R.W., Falsey, A.R., Kitchin, D., Absalon, J., Gurtman, A., et al. (2020, October 14). Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates. The New England Journal of Medicine. DOI: 10.1056/NEJMoa2027906. 
2. Anderson, E.J., Rouphael, N.G., Widge, A.T., Jackson, L.A., Roberts, P.C., Makhene, M., et al. (2020, September 29). Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults. The New England Journal of Medicine. DOI: 10.1056/NEJMoa2028436.
3. Bloom, B.R., Nowak, G.J., Orenstein, W. (2020, September 8). “When Will We Have a Vaccine?” — Understanding Questions and Answers about Covid-19 Vaccination. The New England Journal of Medicine. DOI: 10.1056/NEJMp2025331.

Accessibility Statement
 Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, please contact the CME Conference Coordinator.

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: http://lane.stanford.edu/portals/cultural.html

For activity related questions, please contact
     Email: stanfordmedcast@stanford.edu

For CME general questions, please contact 
     Ph: (650)-497-8554
     Email: stanfordcme@stanford.edu

The Stanford University School of Medicine adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education.

There are no relevant financial relationships with ACCME-defined commercial interests for anyone who was in control of the content of this activity. 

Faculty Member Information

Role in activity

Name of commercial interest/Nature of relationship

Ruth Adewuya, MD
Managing Director, CME
Stanford University School of Medicine

Course Director, Faculty

Nothing to disclose

Bali Pulendran, PhD
Violetta L. Horton Professor and Professor of Microbiology and Immunology;
Stanford University

Faculty

Advisory Board-GlaxoSmithKline|Advisory Board-Medicago

This CME Activity is supported in part by educational grants from Novartis.